A. Wisniewski

Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives

L. Siproudhis, L. Beaugerie, J. Fléjou, 2017, Journal of Crohn's & colitis.

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease

H. Sokol, P. Marteau, P. Seksik, 2016, Alimentary pharmacology & therapeutics.

Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines

H. Sokol, P. Marteau, P. Seksik, 2020, United European gastroenterology journal.

Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue—A Case Report and Brief Literature Review

R. Arcand, T. Manière, M. Bensoussan, 2016, Canadian journal of gastroenterology & hepatology.